Industry Research Reports
Home > Reports > Service & Software > Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-11-27
Pages: 88 Pages
Report ld: 4649385
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cell therapy platform Market Size(US$)
CAGR 2025-2031
14.2%
Market Size,2031
USD 10,419
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 4,697 million
Market Forecast in 2031(Value)
US$ 10,419 million
CAGR
14.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Cell therapy platform was estimated to be worth US$ 4137 million in 2024 and is forecast to a readjusted size of US$ 10419 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
A cell therapy platform refers to a comprehensive system built around the research, development, production, and clinical translation of cell-based therapeutic products (such as CAR-T, TCR-T, NK cells, and stem cells). It includes the technical and equipment support for the entire process, from cell source acquisition, isolation and purification, gene editing, expansion and culture, quality control, cryopreservation and transportation, to clinical drug delivery. This platform improves the safety, consistency, and scalable production capabilities of cell therapy through standardized, automated, and closed-loop process systems, accelerating the transition of cell therapy from the laboratory to clinical applications.
The downstream of cell therapy platforms primarily serves hospitals and clinical departments, cell therapy companies, biopharmaceutical companies, and research institutions, and is applied to the clinical translation of cell preparations, personalized treatment implementation, outsourced process development, and support for large-scale clinical trials. Due to the high technical barriers, complex production systems, and stringent quality standards of cell therapy, platform services command a significant professional premium; therefore, downstream orders typically have high profit margins, with a general gross profit margin of around 56%.
As the forefront of modern biomedical technology, the cell therapy platform is leading to major breakthroughs in personalized medicine and regenerative medicine. It provides innovative treatment options for a variety of intractable diseases, especially in the treatment of cancer, genetic diseases and immune system diseases. With the continuous development of gene editing technology, cell expansion processes and biomaterials, the cell therapy platform will further optimize the preparation, storage and transportation of cells, and improve the safety and effectiveness of treatment. Despite the technical complexity, high costs and regulatory challenges, the rapid development of the cell therapy platform indicates that it is expected to provide more patients with customized and precise treatment options in the future, pushing the medical field to new heights.
This report aims to provide a comprehensive presentation of the global market for Cell therapy platform, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell therapy platform by region & country, by Type, and by Application.
The Cell therapy platform market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell therapy platform.
MARKET SEGMENTATION
By Company
- Novartis
- Gilead Sciences
- Regeneron Pharmaceuticals
- Takeda Pharmaceuticals
- Roche
- Bluebird Bio
- Cellectis
- Sangamo Therapeutics
- Fate Therapeutics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Autologous Cell Therapy Platform
- Allogeneic Cell Therapy Platform
- Others
Segment by Application
- General Hospital
- Specialized Hospital
- Others
Segment by Category
- Immunotherapy Platform
- Stem Cell Therapy Platform
- Genetically Modified Cell Therapy Platform
Segment by Division
- Manually Operated Platform
- Semi-Automated Cell Therapy Platform
- Fully Automated Closed-Loop Cell Therapy Platform
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell therapy platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cell therapy platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cell therapy platform in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cell therapy platform Product Introduction
1.2 Global Cell therapy platform Market Size Forecast (2020-2031)
1.3 Cell therapy platform Market Trends & Drivers
1.3.1 Cell therapy platform Industry Trends
1.3.2 Cell therapy platform Market Drivers & Opportunity
1.3.3 Cell therapy platform Market Challenges
1.3.4 Cell therapy platform Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell therapy platform Players Revenue Ranking (2024)
2.2 Global Cell therapy platform Revenue by Company (2020-2025)
2.3 Key Companies Cell therapy platform Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell therapy platform Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell therapy platform
2.6 Cell therapy platform Market Competitive Analysis
2.6.1 Cell therapy platform Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Cell therapy platform Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell therapy platform as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Autologous Cell Therapy Platform
3.1.2 Allogeneic Cell Therapy Platform
3.1.3 Others
3.2 Global Cell therapy platform Sales Value by Type
3.2.1 Global Cell therapy platform Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cell therapy platform Sales Value, by Type (2020-2031)
3.2.3 Global Cell therapy platform Sales Value, by Type (%) (2020-2031)
4 Segmentation by Treatment Cell Type
4.1 Introduction by Treatment Cell Type
4.1.1 Immunotherapy Platform
4.1.2 Stem Cell Therapy Platform
4.1.3 Genetically Modified Cell Therapy Platform
4.2 Global Cell therapy platform Sales Value by Treatment Cell Type
4.2.1 Global Cell therapy platform Sales Value by Treatment Cell Type (2020 VS 2024 VS 2031)
4.2.2 Global Cell therapy platform Sales Value, by Treatment Cell Type (2020-2031)
4.2.3 Global Cell therapy platform Sales Value, by Treatment Cell Type (%) (2020-2031)
5 Segmentation by Technical System
5.1 Introduction by Technical System
5.1.1 Manually Operated Platform
5.1.2 Semi-Automated Cell Therapy Platform
5.1.3 Fully Automated Closed-Loop Cell Therapy Platform
5.2 Global Cell therapy platform Sales Value by Technical System
5.2.1 Global Cell therapy platform Sales Value by Technical System (2020 VS 2024 VS 2031)
5.2.2 Global Cell therapy platform Sales Value, by Technical System (2020-2031)
5.2.3 Global Cell therapy platform Sales Value, by Technical System (%) (2020-2031)
6 Segmentation by Application
6.1 Introduction by Application
6.1.1 General Hospital
6.1.2 Specialized Hospital
6.1.3 Others
6.2 Global Cell therapy platform Sales Value by Application
6.2.1 Global Cell therapy platform Sales Value by Application (2020 VS 2024 VS 2031)
6.2.2 Global Cell therapy platform Sales Value, by Application (2020-2031)
6.2.3 Global Cell therapy platform Sales Value, by Application (%) (2020-2031)
7 Segmentation by Region
7.1 Global Cell therapy platform Sales Value by Region
7.1.1 Global Cell therapy platform Sales Value by Region: 2020 VS 2024 VS 2031
7.1.2 Global Cell therapy platform Sales Value by Region (2020-2025)
7.1.3 Global Cell therapy platform Sales Value by Region (2026-2031)
7.1.4 Global Cell therapy platform Sales Value by Region (%), (2020-2031)
7.2 North America
7.2.1 North America Cell therapy platform Sales Value, 2020-2031
7.2.2 North America Cell therapy platform Sales Value by Country (%), 2024 VS 2031
7.3 Europe
7.3.1 Europe Cell therapy platform Sales Value, 2020-2031
7.3.2 Europe Cell therapy platform Sales Value by Country (%), 2024 VS 2031
7.4 Asia Pacific
7.4.1 Asia Pacific Cell therapy platform Sales Value, 2020-2031
7.4.2 Asia Pacific Cell therapy platform Sales Value by Region (%), 2024 VS 2031
7.5 South America
7.5.1 South America Cell therapy platform Sales Value, 2020-2031
7.5.2 South America Cell therapy platform Sales Value by Country (%), 2024 VS 2031
7.6 Middle East & Africa
7.6.1 Middle East & Africa Cell therapy platform Sales Value, 2020-2031
7.6.2 Middle East & Africa Cell therapy platform Sales Value by Country (%), 2024 VS 2031
8 Segmentation by Key Countries/Regions
8.1 Key Countries/Regions Cell therapy platform Sales Value Growth Trends, 2020 VS 2024 VS 2031
8.2 Key Countries/Regions Cell therapy platform Sales Value, 2020-2031
8.3 United States
8.3.1 United States Cell therapy platform Sales Value, 2020-2031
8.3.2 United States Cell therapy platform Sales Value by Type (%), 2024 VS 2031
8.3.3 United States Cell therapy platform Sales Value by Application, 2024 VS 2031
8.4 Europe
8.4.1 Europe Cell therapy platform Sales Value, 2020-2031
8.4.2 Europe Cell therapy platform Sales Value by Type (%), 2024 VS 2031
8.4.3 Europe Cell therapy platform Sales Value by Application, 2024 VS 2031
8.5 China
8.5.1 China Cell therapy platform Sales Value, 2020-2031
8.5.2 China Cell therapy platform Sales Value by Type (%), 2024 VS 2031
8.5.3 China Cell therapy platform Sales Value by Application, 2024 VS 2031
8.6 Japan
8.6.1 Japan Cell therapy platform Sales Value, 2020-2031
8.6.2 Japan Cell therapy platform Sales Value by Type (%), 2024 VS 2031
8.6.3 Japan Cell therapy platform Sales Value by Application, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Cell therapy platform Sales Value, 2020-2031
8.7.2 South Korea Cell therapy platform Sales Value by Type (%), 2024 VS 2031
8.7.3 South Korea Cell therapy platform Sales Value by Application, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Cell therapy platform Sales Value, 2020-2031
8.8.2 Southeast Asia Cell therapy platform Sales Value by Type (%), 2024 VS 2031
8.8.3 Southeast Asia Cell therapy platform Sales Value by Application, 2024 VS 2031
8.9 India
8.9.1 India Cell therapy platform Sales Value, 2020-2031
8.9.2 India Cell therapy platform Sales Value by Type (%), 2024 VS 2031
8.9.3 India Cell therapy platform Sales Value by Application, 2024 VS 2031
9 Company Profiles
9.1 Novartis
9.1.1 Novartis Profile
9.1.2 Novartis Main Business
9.1.3 Novartis Cell therapy platform Products, Services and Solutions
9.1.4 Novartis Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.1.5 Novartis Recent Developments
9.2 Gilead Sciences
9.2.1 Gilead Sciences Profile
9.2.2 Gilead Sciences Main Business
9.2.3 Gilead Sciences Cell therapy platform Products, Services and Solutions
9.2.4 Gilead Sciences Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.2.5 Gilead Sciences Recent Developments
9.3 Regeneron Pharmaceuticals
9.3.1 Regeneron Pharmaceuticals Profile
9.3.2 Regeneron Pharmaceuticals Main Business
9.3.3 Regeneron Pharmaceuticals Cell therapy platform Products, Services and Solutions
9.3.4 Regeneron Pharmaceuticals Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.3.5 Regeneron Pharmaceuticals Recent Developments
9.4 Takeda Pharmaceuticals
9.4.1 Takeda Pharmaceuticals Profile
9.4.2 Takeda Pharmaceuticals Main Business
9.4.3 Takeda Pharmaceuticals Cell therapy platform Products, Services and Solutions
9.4.4 Takeda Pharmaceuticals Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.4.5 Takeda Pharmaceuticals Recent Developments
9.5 Roche
9.5.1 Roche Profile
9.5.2 Roche Main Business
9.5.3 Roche Cell therapy platform Products, Services and Solutions
9.5.4 Roche Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.5.5 Roche Recent Developments
9.6 Bluebird Bio
9.6.1 Bluebird Bio Profile
9.6.2 Bluebird Bio Main Business
9.6.3 Bluebird Bio Cell therapy platform Products, Services and Solutions
9.6.4 Bluebird Bio Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.6.5 Bluebird Bio Recent Developments
9.7 Cellectis
9.7.1 Cellectis Profile
9.7.2 Cellectis Main Business
9.7.3 Cellectis Cell therapy platform Products, Services and Solutions
9.7.4 Cellectis Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.7.5 Cellectis Recent Developments
9.8 Sangamo Therapeutics
9.8.1 Sangamo Therapeutics Profile
9.8.2 Sangamo Therapeutics Main Business
9.8.3 Sangamo Therapeutics Cell therapy platform Products, Services and Solutions
9.8.4 Sangamo Therapeutics Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.8.5 Sangamo Therapeutics Recent Developments
9.9 Fate Therapeutics
9.9.1 Fate Therapeutics Profile
9.9.2 Fate Therapeutics Main Business
9.9.3 Fate Therapeutics Cell therapy platform Products, Services and Solutions
9.9.4 Fate Therapeutics Cell therapy platform Revenue (US$ Million) & (2020-2025)
9.9.5 Fate Therapeutics Recent Developments
10 Industry Chain Analysis
10.1 Cell therapy platform Industrial Chain
10.2 Cell therapy platform Upstream Analysis
10.2.1 Key Raw Materials
10.2.2 Raw Materials Key Suppliers
10.2.3 Manufacturing Cost Structure
10.3 Midstream Analysis
10.4 Downstream Analysis (Customers Analysis)
10.5 Sales Model and Sales Channels
10.5.1 Cell therapy platform Sales Model
10.5.2 Sales Channel
10.5.3 Cell therapy platform Distributors
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Cell therapy platform Market Trends
Table 2. Cell therapy platform Market Drivers & Opportunity
Table 3. Cell therapy platform Market Challenges
Table 4. Cell therapy platform Market Restraints
Table 5. Global Cell therapy platform Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Cell therapy platform Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Cell therapy platform Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cell therapy platform Product Type
Table 9. Key Companies Time to Begin Mass Production of Cell therapy platform
Table 10. Global Cell therapy platform Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell therapy platform as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cell therapy platform Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Cell therapy platform Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Cell therapy platform Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Cell therapy platform Sales Market Share in Value by Type (2020-2025)
Table 17. Global Cell therapy platform Sales Market Share in Value by Type (2026-2031)
Table 18. Global Cell therapy platform Sales Value by Treatment Cell Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Cell therapy platform Sales Value by Treatment Cell Type (2020-2025) & (US$ Million)
Table 20. Global Cell therapy platform Sales Value by Treatment Cell Type (2026-2031) & (US$ Million)
Table 21. Global Cell therapy platform Sales Market Share in Value by Treatment Cell Type (2020-2025)
Table 22. Global Cell therapy platform Sales Market Share in Value by Treatment Cell Type (2026-2031)
Table 23. Global Cell therapy platform Sales Value by Technical System: 2020 VS 2024 VS 2031 (US$ Million)
Table 24. Global Cell therapy platform Sales Value by Technical System (2020-2025) & (US$ Million)
Table 25. Global Cell therapy platform Sales Value by Technical System (2026-2031) & (US$ Million)
Table 26. Global Cell therapy platform Sales Market Share in Value by Technical System (2020-2025)
Table 27. Global Cell therapy platform Sales Market Share in Value by Technical System (2026-2031)
Table 28. Global Cell therapy platform Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Cell therapy platform Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Cell therapy platform Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Cell therapy platform Sales Market Share in Value by Application (2020-2025)
Table 32. Global Cell therapy platform Sales Market Share in Value by Application (2026-2031)
Table 33. Global Cell therapy platform Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 34. Global Cell therapy platform Sales Value by Region (2020-2025) & (US$ Million)
Table 35. Global Cell therapy platform Sales Value by Region (2026-2031) & (US$ Million)
Table 36. Global Cell therapy platform Sales Value by Region (2020-2025) & (%)
Table 37. Global Cell therapy platform Sales Value by Region (2026-2031) & (%)
Table 38. Key Countries/Regions Cell therapy platform Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 39. Key Countries/Regions Cell therapy platform Sales Value, (2020-2025) & (US$ Million)
Table 40. Key Countries/Regions Cell therapy platform Sales Value, (2026-2031) & (US$ Million)
Table 41. Novartis Basic Information List
Table 42. Novartis Description and Business Overview
Table 43. Novartis Cell therapy platform Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cell therapy platform Business of Novartis (2020-2025)
Table 45. Novartis Recent Developments
Table 46. Gilead Sciences Basic Information List
Table 47. Gilead Sciences Description and Business Overview
Table 48. Gilead Sciences Cell therapy platform Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cell therapy platform Business of Gilead Sciences (2020-2025)
Table 50. Gilead Sciences Recent Developments
Table 51. Regeneron Pharmaceuticals Basic Information List
Table 52. Regeneron Pharmaceuticals Description and Business Overview
Table 53. Regeneron Pharmaceuticals Cell therapy platform Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cell therapy platform Business of Regeneron Pharmaceuticals (2020-2025)
Table 55. Regeneron Pharmaceuticals Recent Developments
Table 56. Takeda Pharmaceuticals Basic Information List
Table 57. Takeda Pharmaceuticals Description and Business Overview
Table 58. Takeda Pharmaceuticals Cell therapy platform Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cell therapy platform Business of Takeda Pharmaceuticals (2020-2025)
Table 60. Takeda Pharmaceuticals Recent Developments
Table 61. Roche Basic Information List
Table 62. Roche Description and Business Overview
Table 63. Roche Cell therapy platform Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cell therapy platform Business of Roche (2020-2025)
Table 65. Roche Recent Developments
Table 66. Bluebird Bio Basic Information List
Table 67. Bluebird Bio Description and Business Overview
Table 68. Bluebird Bio Cell therapy platform Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cell therapy platform Business of Bluebird Bio (2020-2025)
Table 70. Bluebird Bio Recent Developments
Table 71. Cellectis Basic Information List
Table 72. Cellectis Description and Business Overview
Table 73. Cellectis Cell therapy platform Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cell therapy platform Business of Cellectis (2020-2025)
Table 75. Cellectis Recent Developments
Table 76. Sangamo Therapeutics Basic Information List
Table 77. Sangamo Therapeutics Description and Business Overview
Table 78. Sangamo Therapeutics Cell therapy platform Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cell therapy platform Business of Sangamo Therapeutics (2020-2025)
Table 80. Sangamo Therapeutics Recent Developments
Table 81. Fate Therapeutics Basic Information List
Table 82. Fate Therapeutics Description and Business Overview
Table 83. Fate Therapeutics Cell therapy platform Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cell therapy platform Business of Fate Therapeutics (2020-2025)
Table 85. Fate Therapeutics Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Cell therapy platform Downstream Customers
Table 89. Cell therapy platform Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell therapy platform Product Picture
Figure 2. Global Cell therapy platform Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Cell therapy platform Sales Value (2020-2031) & (US$ Million)
Figure 4. Cell therapy platform Report Years Considered
Figure 5. Global Cell therapy platform Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cell therapy platform Revenue in 2024
Figure 7. Cell therapy platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Autologous Cell Therapy Platform Picture
Figure 9. Allogeneic Cell Therapy Platform Picture
Figure 10. Others Picture
Figure 11. Global Cell therapy platform Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Cell therapy platform Sales Value Market Share by Type, 2024 & 2031
Figure 13. Immunotherapy Platform Picture
Figure 14. Stem Cell Therapy Platform Picture
Figure 15. Genetically Modified Cell Therapy Platform Picture
Figure 16. Global Cell therapy platform Sales Value by Treatment Cell Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Cell therapy platform Sales Value Market Share by Treatment Cell Type, 2024 & 2031
Figure 18. Manually Operated Platform Picture
Figure 19. Semi-Automated Cell Therapy Platform Picture
Figure 20. Fully Automated Closed-Loop Cell Therapy Platform Picture
Figure 21. Global Cell therapy platform Sales Value by Technical System (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Cell therapy platform Sales Value Market Share by Technical System, 2024 & 2031
Figure 23. Product Picture of General Hospital
Figure 24. Product Picture of Specialized Hospital
Figure 25. Product Picture of Others
Figure 26. Global Cell therapy platform Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 27. Global Cell therapy platform Sales Value Market Share by Application, 2024 & 2031
Figure 28. North America Cell therapy platform Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Cell therapy platform Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Cell therapy platform Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Cell therapy platform Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Cell therapy platform Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Cell therapy platform Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Cell therapy platform Sales Value (%), (2020-2031)
Figure 39. United States Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Cell therapy platform Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Cell therapy platform Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Cell therapy platform Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Cell therapy platform Sales Value by Application (%), 2024 VS 2031
Figure 45. China Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Cell therapy platform Sales Value by Type (%), 2024 VS 2031
Figure 47. China Cell therapy platform Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Cell therapy platform Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Cell therapy platform Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Cell therapy platform Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Cell therapy platform Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Cell therapy platform Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Cell therapy platform Sales Value by Application (%), 2024 VS 2031
Figure 57. India Cell therapy platform Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Cell therapy platform Sales Value by Type (%), 2024 VS 2031
Figure 59. India Cell therapy platform Sales Value by Application (%), 2024 VS 2031
Figure 60. Cell therapy platform Industrial Chain
Figure 61. Cell therapy platform Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Cell therapy platform market size from 2025 to 2031?
The annual compound growth rate of the global Cell therapy platform market is 14.2% 2025 to 2031.
Which region is expected to have the highest market share?
What was the global market size of Cell therapy platform in 2031?
Which companies rank high in the global Cell therapy platform market?
What was the global market size of Cell therapy platform in 2025?
Related Reports
Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell therapy platform market is projected to grow from US$ 4697 million in 2025 to US$ 11750 million by 2032, at a CAGR of 14.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 125
USD 4900.00
(Single User License)
Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell therapy platform market size was US$ 4697 million in 2025 and is forecast to reach a readjusted size of US$ 11750 million by 2032 with a CAGR of 14.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 80
USD 4250.00
(Single User License)
Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell therapy platform was estimated to be worth US$ 4697 million in 2025 and is projected to reach US$ 11750 million, growing at a CAGR of 14.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 92
USD 3950.00
(Single User License)
Global Cell therapy platform Market Research Report 2026
The global Cell therapy platform market was valued at US$ 4697 million in 2025 and is anticipated to reach US$ 11750 million by 2032, at a CAGR of 14.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 106
USD 2900.00
(Single User License)
Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell therapy platform market size was US$ 4137 million in 2024 and is forecast to a readjusted size of US$ 10419 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published Date: 2025-11-27
Pages: 77
USD 4250.00
(Single User License)
Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell therapy platform market is projected to grow from US$ 4137 million in 2024 to US$ 10419 million by 2031, at a CAGR of 14.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-27
Pages: 130
USD 4900.00
(Single User License)
Global Cell therapy platform Market Research Report 2025
The global market for Cell therapy platform was valued at US$ 4137 million in the year 2024 and is projected to reach a revised size of US$ 10419 million by 2031, growing at a CAGR of 14.2% during the forecast period.
Published Date: 2025-11-27
Pages: 79
USD 2900.00
(Single User License)
Global Cell therapy platform Market Research Report 2024
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published Date: 2024-10-26
Pages: 72
USD 2900.00
(Single User License)
Global and United States Cell therapy platform Market Report & Forecast 2024-2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published Date: 2024-10-26
Pages: 96
USD 4350.00
(Single User License)
Global Cell therapy platform Market Insights, Forecast to 2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published Date: 2024-10-26
Pages: 123
USD 4900.00
(Single User License)
Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell therapy platform market is projected to grow from US$ 4697 million in 2025 to US$ 11750 million by 2032, at a CAGR of 14.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 125
USD 4900.00 (Single User License)Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell therapy platform market size was US$ 4697 million in 2025 and is forecast to reach a readjusted size of US$ 11750 million by 2032 with a CAGR of 14.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 80
USD 4250.00 (Single User License)Cell therapy platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell therapy platform was estimated to be worth US$ 4697 million in 2025 and is projected to reach US$ 11750 million, growing at a CAGR of 14.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 92
USD 3950.00 (Single User License)Global Cell therapy platform Market Research Report 2026
The global Cell therapy platform market was valued at US$ 4697 million in 2025 and is anticipated to reach US$ 11750 million by 2032, at a CAGR of 14.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 106
USD 2900.00 (Single User License)Global Cell therapy platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell therapy platform market size was US$ 4137 million in 2024 and is forecast to a readjusted size of US$ 10419 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 77
USD 4250.00 (Single User License)Global Cell therapy platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell therapy platform market is projected to grow from US$ 4137 million in 2024 to US$ 10419 million by 2031, at a CAGR of 14.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-27
Pages: 130
USD 4900.00 (Single User License)Global Cell therapy platform Market Research Report 2025
The global market for Cell therapy platform was valued at US$ 4137 million in the year 2024 and is projected to reach a revised size of US$ 10419 million by 2031, growing at a CAGR of 14.2% during the forecast period.
Published: 2025-11-27
Pages: 79
USD 2900.00 (Single User License)Global Cell therapy platform Market Research Report 2024
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published: 2024-10-26
Pages: 72
USD 2900.00 (Single User License)Global and United States Cell therapy platform Market Report & Forecast 2024-2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published: 2024-10-26
Pages: 96
USD 4350.00 (Single User License)Global Cell therapy platform Market Insights, Forecast to 2030
A cell therapy platform refers to a comprehensive system that supports the research, development, processing, preparation and application of cells through a series of technologies, equipment and processes. The platform is used to develop and produce living cell-based therapies, including immune cell therapy, stem cell therapy and gene-modified cell therapy. These therapies are widely used in the fields of cancer, genetic diseases, immune system diseases and tissue repair, and aim to achieve therapeutic effects by enhancing or repairing the patient's cell function. The platform usually covers multiple links such as cell separation, amplification, gene editing, quality control and clinical application.
Published: 2024-10-26
Pages: 123
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now